FILTER
FILTERED INTERVIEW RESULTS
Martín Toscano
PRESIDENT, EVONIK INDUSTRIES MEXICO
"Evonik can support industries in moving from a linear economy into a circular economy with the help of specialty chemicals."
Alberto Laveran
SENIOR VICE PRESIDENT – LATAM REGION, VANTAGE SPECIALTY CHEMICALS
“We chose Bogotá as Vantage’s Latam HQ because of its strategic location to serve the region with connection to every single market. The Bogotá office is doing so well that we are now providing some global operations support to our US offices.”
Felipe Varela
DIRECTOR GENERAL, GRUPO DYNASOL
“In Mexico, we are the benchmark of the synthetic rubber industry, and thanks to the current capacity that we have, we export around 60% of our production.”
Alonzo Autrey
MANAGING DIRECTOR, DVA MEXICANA
“In countries like Mexico, everything related to chronic degenerative illnesses will be a priority for laboratories focused on generic products. The demand for these products means there is an opportunity to have generic treatments available at lower prices.”
Aldimir Torres
PRESIDENT, MEXICO’S NATIONAL ASSOCIATION OF PLASTIC INDUSTRIES (ANIPAC)
ANIPAC explains its mission is to promote the competitiveness and sustainability of the Mexican plastics industry.
Ricardo Méndez Pastrana
DIRECTOR GENERAL, PROMAPLAST
Chemical distributor PromaPlast details the milestones achieved on its 25th anniversary.
Adrian Duhalt
POST-DOCTORATE FELLOW – MEXICAN ENERGY STUDIES, BAKER INSTITUTE
Adrian Duhalt analyzes Mexico’s petrochemical sector and future industry trends.
Jorge Buckup
PRESIDENT – LATIN AMERICA, UNIVAR SOLUTIONS
Univar Solutions explains its digital strategy and focus on sustainability.
Patricio Cueva
CEO, REACCIONES QUÍMICAS
Reacciones Químicas outlines opportunities in Mexico’s coatings segment.
German Torres
REGIONAL PRESIDENT, BRENNTAG ESSENTIALS LATIN AMERICA
Brenntag explains the role of the chemical distribution segment in Latin America.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
